The Effect of Patient's Position After Intra-tympanic Injection
NCT04384640 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-05-12
Summary
The effect of the patient's head on the leakage of steroids from the middle ear to the throat will be studied. The patients will be seated after one of the intra tympanic injections that are routonely performed due to Sudden Sensorineural Hearin Loss (SNHL). The patients will be asked if they taste the steroids in their throats.
Conditions
- Sudden Hearing Loss
Interventions
- OTHER
-
Change of posture after Intra Tympanic injection
Seating position after Intra Tympanic injection
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2021-06-30
- Completion
- 2021-06-30
More Related Trials
-
Intratympanic Steroids for Sudden Hearing Loss
NCT04129697 ·Status: UNKNOWN ·Phase: NA
-
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
NCT04794842 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Sudden Deafness Treatment Trial
NCT00097448 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
NCT00335920 ·Status: COMPLETED ·Phase: PHASE3
-
Sudden Hearing Loss Multi-center Clinical Trial
NCT02026479 ·Status: UNKNOWN ·Phase: NA
-
Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
NCT06878599 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss
NCT06997406 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Vestibular Prognosis Assessment of ISSNHL With Vestibular Dysfunction Treated With Oral or Intratympanic Glucocorticoids
NCT03974867 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
NCT07235488 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Adding Lidocaine to Dexamethasone in Intra-tympanic Injection for Management of Tinnitus
NCT03265197 ·Status: COMPLETED ·Phase: PHASE1
-
High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
NCT03255473 ·Status: WITHDRAWN ·Phase: PHASE2
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3
NCT01925495 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
NCT04397354 ·Status: COMPLETED ·Phase: NA
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Triamcinolone Levels in Cochlear Perilymph
NCT03248856 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of The Efficacy of Intratympanic Platelet Rich Plasma for Treatment of Sensorineural Hearing Loss.
NCT05786378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear Implantation
NCT01588925 ·Status: COMPLETED ·Phase: PHASE2
-
Small Sample,Unicentric,Randomized, Controlled Clinical Study of Coenzyme I for Injection in the Treatment of Sudden Sensorineural Hearing Loss
NCT05849519 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
NCT00416143 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Observation of Gas Exchange in the Middle Ear
NCT00794105 ·Status: UNKNOWN
-
Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus
NCT00860808 ·Status: COMPLETED ·Phase: PHASE2
-
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
NCT05851508 ·Status: RECRUITING ·Phase: PHASE3
-
Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss
NCT05112354 ·Status: COMPLETED ·Phase: PHASE2
-
Hydrogen-oxygen Gas Mixture Inhalation in Patients With Sudden Sensorineural Hearing Loss
NCT04881435 ·Status: UNKNOWN ·Phase: NA
-
Phase I Clinical Study of HY01 in Patients
NCT04961099 ·Status: UNKNOWN ·Phase: PHASE1